guardian | “Fungi are everywhere,” said Prof Gordon Brown, head of the Aberdeen mycology centre.
“We breathe in more than 100 spores of aspergillus every day.
Normally our immune systems mop them up but, when our disease defences
are compromised – for example, during cancer treatments or after
traumatic injuries – they lose the ability to fight back.
“Fungi can spread through patients’ bodies and into their spines and
brains. Patients who would otherwise survive treatments are dying every
year from such infections.”
This point was also stressed by Prof Neil Gow, another Aberdeen
researcher. “Essentially fatal fungal infections are diseases of the
diseased,” he said.
In addition, premature babies and patients with the inherited condition cystic fibrosis are also vulnerable.
However, the problem is even worse in developing countries. In
sub-Saharan nations, where millions are infected with HIV – which causes
severe depletion of patients’ immune systems – infections with
cryptococcus and pneumocystis fungi account for more than half a million
deaths a year.
“The total global number of fungal deaths is about the same as the
number of deaths from malaria but the amount that is spent on fungal
infection research is only a fraction of the cash that goes on malaria
research,” added Gow.
A vaccine that could protect against fungal disease has yet to be
developed, while the rise of resistance to the class of medicines known
as azole drugs is causing alarm among doctors.
Recent reports from the US and Europe indicate that resistance to
azole drugs is increasing in both aspergillus and candida fungi. The
widespread use of agricultural fungicides to protect crops and their use
in some paints and coatings has been linked to the rise of this
resistance.